The phenotype–genotype study showed that susceptibility variants in THADA and INSR conferred risk for metabolic syndrome, and variants of DENND1A and TOX3 were associated with insulin resistance in PCOS women [9,10]. This evidence concerns the gene INSR and metabolic syndrome.